|
DDX46 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.03399999999521E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.415900E-03 |
| Normal-vs-Stage2 |
2.246100E-02 |
| Normal-vs-Stage3 |
1.19430000000698E-06 |
| Normal-vs-Stage4 |
2.92610000007798E-07 |
| Stage1-vs-Stage2 |
4.642400E-01 |
| Stage1-vs-Stage3 |
1.996720E-03 |
| Stage1-vs-Stage4 |
9.030600E-04 |
| Stage2-vs-Stage3 |
2.143600E-01 |
| Stage2-vs-Stage4 |
1.089770E-01 |
| Stage3-vs-Stage4 |
5.586800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.28159999999811E-05 |
| Normal-vs-AfricanAmerican |
1.075910E-03 |
| Normal-vs-Asian |
4.603200E-01 |
| Caucasian-vs-AfricanAmerican |
6.732400E-01 |
| Caucasian-vs-Asian |
5.014800E-01 |
| AfricanAmerican-vs-Asian |
4.126600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.94579999998912E-06 |
| Normal-vs-Female |
2.563700E-03 |
| Male-vs-Female |
2.271800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.986300E-04 |
| Normal-vs-Age(41-60Yrs) |
5.389100E-04 |
| Normal-vs-Age(61-80Yrs) |
3.77310000000408E-05 |
| Normal-vs-Age(81-100Yrs) |
2.995100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.519800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.157400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.108600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.028000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.470600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.332600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.673600E-01 |
| Normal-vs-Grade 2 |
8.983800E-03 |
| Normal-vs-Grade 3 |
1.62162999999271E-05 |
| Normal-vs-Grade 4 |
8.24660000287025E-08 |
| Grade 1-vs-Grade 2 |
1.148420E-01 |
| Grade 1-vs-Grade 3 |
7.484200E-03 |
| Grade 1-vs-Grade 4 |
9.981400E-04 |
| Grade 2-vs-Grade 3 |
1.333950E-02 |
| Grade 2-vs-Grade 4 |
2.361100E-04 |
| Grade 3-vs-Grade 4 |
3.229600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.853800E-01 |
| Normal-vs-ccB subtype |
3.10529999492104E-08 |
| ccA subtype-vs-ccB subtype |
2.36079999993422E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.56859999999437E-05 |
| Normal-vs-N1 |
6.997400E-03 |
| N0-vs-N1 |
5.006800E-01 |
|
|
